Publications are listed alphabetically for the first KCOM co-author of each publication; all KCOM students are indicated by bold font
Janoyan, Jano (DO Class of 2002): Darmani NA, Janoyan JJ, Kumar N, Crim JL. Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover. Pharmacol Biochem Behav. 2003 Jul;75(4):777-87 PubMed
Janoyan, Jano (DO Class of 2002): Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB(1) receptor characterization, distribution, and G-protein activation. Eur J Pharmacol. 2003 Jan 10;459(1):83-95 PubMed
Janoyan, Jano (DO Class of 2002): Darmani NA, Sim-Selly LJ, Martin BR, Janoyan JJ, Crim JL, Breivogel CS. Antiemetic action of delta 9-tetrahydrocannabinoid and synthetic cannabinoids. In Biology of marijuana: from gene to behavior (E.S. Onaivi, ed), Taylor and Francis Books Ltd, London UK 2002
Janoyan, Jano (DO Class of 2002): Janoyan JJ, Crim JL, Darmani NA. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by [Delta](9)-THC and other cannabinoids. Pharmacol Biochem Behav 2002 Jan 2;71(1-2):155-162 PubMed
